The drug Eliquis (apixaban) is used to help prevent blood clots in certain patients. In clinical trials, among 5924 patients treated with Eliquis, 153 developed the adverse reaction of nausea (based on data from Bristol-Myers Squibb Co.). Use a 0.08 significance level to test the claim that 3% of Eliquis users develop nausea. Does nausea appear to be a problematic adverse reaction?
